Skip to main content

Advertisement

Log in

Frequency of seizures in patients with metastatic brain tumors

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Introduction

We sought to determine the influence of primary tumor histology and metastatic tumor location on the frequency of seizures among patients with brain metastases. A secondary aim was to determine if surgery reduced the occurrence and frequency of seizures.

Methods

We retrospectively reviewed patients with cerebral metastasis at a single institution from 2006 to 2016.

Results

Among 1949 patients identified as having had cerebral metastasis, 168 (8.6%) had documentation of one or more seizures. The incidence of seizures was highest among patients with metastases from melanoma (19.8%), followed by those with colon cancer (9.7%), renal cell carcinoma (RCC; 8.3%), and lung cancer (7.0%). Among 1581 patients with melanoma, colon cancer, RCC, non-small cell lung cancer, or breast cancer, having metastases in the frontal lobe seemed to confer the greatest risk of seizures (n = 100), followed by foci in the temporal lobe (n = 20) and elsewhere (n = 16).

Conclusion

Patients with cerebral metastasis are at increased risk for seizures. Seizure rates seem to be higher for certain primary tumors, such as melanoma, colon cancer, and RCC, and for lesions located in the frontal lobe.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Achrol AS, Rennert RC, Anders C, Soffietti R, Ahluwalia MS, Nayak L et al (2019) Brain metastases Nat Rev Dis Primers 5(1):5. https://doi.org/10.1038/s41572-018-0055-y

    Article  PubMed  Google Scholar 

  2. Rick JW, Shahin M, Chandra A, Dalle Ore C, Yue JK, Nguyen A et al (2019) Systemic therapy for brain metastases. Crit Rev Oncol Hematol 142:44–50. https://doi.org/10.1016/j.critrevonc.2019.07.012

    Article  PubMed  PubMed Central  Google Scholar 

  3. Vogelbaum MA, Brown PD, Messersmith H, Brastionos PK, Burri S, Cahill D et al (2022) Treatment for brain metastasis: ASCO-SNO-ASTRO guideline. J Clin Oncol 40(5):492–516. https://doi.org/10.1200/JCO.21.02314

    Article  CAS  PubMed  Google Scholar 

  4. Killock D (2020) ICI for resected stage IV melanoma. Nat Rev Clin Oncol 17(8):450. https://doi.org/10.1038/s41571-020-0397-8

    Article  PubMed  Google Scholar 

  5. Rudà R, Mo F, Pellerino A (2020) Epilepsy in brain metastasis: an emerging entity. Curr Treat Options in Neurol 22(2):6. https://doi.org/10.1007/s11940-020-0613-y

    Article  Google Scholar 

  6. Wolpert F, Lareida A, Terziev R, Grossenbacher B, Neidert MC, Roth P et al (2020) Risk factors for the development of epilepsy in patients with brain metastases. Neuro Oncol 22(5):718–728. https://doi.org/10.1093/neuonc/noz172

    Article  PubMed  Google Scholar 

  7. Chan V, Sahgal A, Egeto P, Schweizer T, Das S (2017) Incidence of seizure in adult patients with intracranial metastatic disease. J Neurooncol 131(3):619–624. https://doi.org/10.1007/s11060-016-2335-2

    Article  PubMed  Google Scholar 

  8. Maschio M (2012) Brain tumor-related epilepsy. Curr Neuropharmacol 10(2):124–133. https://doi.org/10.2174/157015912800604470

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lynam LM, Lyons MK, Drazkowski JF, Sirven JI, Noe KH, Zimmerman RS, Wilkens JA (2007) Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg 109(7):634–638. https://doi.org/10.1016/j.clineuro.2007.05.017

    Article  PubMed  Google Scholar 

  10. Wu A, Weingart JD, Gallia GL, Lim M, Brem H, Bettegowda C, Chaichana KL (2017) Risk factors for preoperative seizures and loss of seizure control in patients undergoing surgery for metastatic brain tumors. World Neurosurg 104:120–128. https://doi.org/10.1016/j.wneu.2017.05.028

    Article  PubMed  Google Scholar 

  11. Oberndorfer S, Schmal T, Lahrmann H, Urbanits S, Lindner K, Grisold W (2002) The frequency of seizures in patients with primary brain tumors or cerebral metastases An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna. Wien Klin Wochenschr 114(21–22):911–916 (article in German)

    PubMed  Google Scholar 

  12. Englot DJ, Chang EF, Vecht CJ (2016) Epilepsy and brain tumors. Handb Clin Neurol 134:267–285. https://doi.org/10.1016/B978-0-12-802997-8.00016-5

    Article  PubMed  PubMed Central  Google Scholar 

  13. Rudà R, Trevisan E, Soffietti R (2010) Epilepsy and brain tumors. Curr Opin Oncol 22(6):611–620. https://doi.org/10.1097/CCO.0b013e32833de99d

    Article  PubMed  Google Scholar 

  14. Ajinkya S, Fox J, Houston P, Greenblatt A, Lekoubou A, Lindhorst S, Cachia D, Olar A, Kutluay E (2021) Seizures in patients with metastatic brain tumors: Prevalence, clinical characteristics, and features on EEG. J Clin Neurophysiol 38(2):143–148. https://doi.org/10.1097/WNP.0000000000000671

    Article  PubMed  Google Scholar 

  15. Goldlust S, Hsu M, Lassman A, Panageas K, Avila E (2012) Seizure prophylaxis and melanoma brain metastases. J Neurooncol 108(1):109–114. https://doi.org/10.1007/s11060-012-0802-y

    Article  CAS  PubMed  Google Scholar 

  16. Lamba N, Catalano PJ, Cagney DN, Haas-Kogan DA, Bubrick EJ, Wen PY, Aizer AA (2021) Seizures among patients with brain metastases: a population-and institutional-level analysis. Neurology 96(8):e1237–e1250. https://doi.org/10.1212/WNL.0000000000011459

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Berto P (2002) Quality of life in patients with epilepsy and impact of treatments. Pharmacoeconomics 20(15):1039–1059. https://doi.org/10.2165/00019053-200220150-00002

    Article  PubMed  Google Scholar 

  18. Soffietti R, Rudà R, Mutani R (2002) Management of brain metastases. J Neurol 249(10):1357–1369. https://doi.org/10.1007/s00415-002-0870-6

    Article  PubMed  Google Scholar 

  19. Zacest AC, Besser M, Stevens G, Thompson JF, McCarthy WH, Culjak G (2002) Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. J Neurosurg 96(3):552–558. https://doi.org/10.3171/jns.2002.96.3.0552

    Article  PubMed  Google Scholar 

  20. Van Vliet EA, da Costa AS, Redeker S, Van Schaik R, Aronica E, Gorter J (2007) Blood–brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130(2):521–534. https://doi.org/10.1093/brain/awl318

    Article  PubMed  Google Scholar 

  21. Ivens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, Tomkins O, Seiffert E, Heinemann U, Friedman A (2007) TGF-β receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130(2):535–547. https://doi.org/10.1093/brain/awl317

    Article  PubMed  Google Scholar 

  22. Jung M, Ahn JB, Chang JH, Suh CO, Hong S, Roh JK, Shin SJ, Rha SY (2011) Brain metastases from colorectal carcinoma: prognostic factors and outcome. J Neurooncol 101(1):49–55. https://doi.org/10.1007/s11060-010-0214-9

    Article  PubMed  Google Scholar 

  23. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22(14):2865–2872. https://doi.org/10.1200/JCO.2004.12.149

    Article  PubMed  Google Scholar 

  24. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94(10):2698–2705. https://doi.org/10.1002/cncr.10541

    Article  PubMed  Google Scholar 

  25. Koo T, Kim K, Park HJ, Han SW, Kim TY, Jeong SY, Park KJ, Chie EK (2020) Prognostic factors for survival in colorectal cancer patients with brain metastases undergoing whole brain radiotherapy: Multicenter retrospective study. Sci Rep 10(1):4340. https://doi.org/10.1038/s41598-020-61354-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Mongan JP, Fadul CE, Cole BF, Zaki BI, Suriawinata AA, Ripple GH, Tosteson TD, Pipas JM (2009) Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines. Clin Colorectal Cancer 8(2):100–105. https://doi.org/10.3816/CCC.2009.n.016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. de Groot M, Reijneveld JC, Aronica E, Heimans JJ (2012) Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment. Brain 135(4):1002–1016. https://doi.org/10.1093/brain/awr310

    Article  PubMed  Google Scholar 

  28. Zaatreh MM, Spencer DD, Thompson JL, Blumenfeld H, Novotny EJ, Mattson RH, Spencer SS (2002) Frontal lobe tumoral epilepsy: clinical, neurophysiologic features and predictors of surgical outcome. Epilepsia 43(7):727–733. https://doi.org/10.1046/j.1528-1157.2002.39501.x

    Article  PubMed  Google Scholar 

  29. Garcia JH, Morshed RA, Chung J, Chavez MAM, Sudhakar V, Saggi S et al (2022) Factors associated with preoperative and postoperative seizures in patients undergoing resection of brain metastases. J Neurosurg 138(1):19–26. https://doi.org/10.3171/2022.3.JNS212285

    Article  PubMed  Google Scholar 

  30. Bagla R, Skidmore CT (2011) Frontal lobe seizures. Neurologist 17(3):125–135. https://doi.org/10.1097/NRL.0b013e31821733db

    Article  PubMed  Google Scholar 

  31. Urban H, Willems LM, Ronellenfitsch MW, Rosenow F, Steinbach JP, Strzelczyk A (2020) Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition. OncoImmunology 9:1. https://doi.org/10.1080/2162402X.2020.1851517

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Christine F. Wogan, MS, ELS, of the Division of Radiation Oncology at The University of Texas MD Anderson Cancer Center, for editorial assistance.

Funding

None/Not applicable.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kristin Huntoon.

Ethics declarations

Ethical approval

The study protocol was approved by the Institutional Review Board.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huntoon, K., Musgrave, N., Shaikhouni, A. et al. Frequency of seizures in patients with metastatic brain tumors. Neurol Sci 44, 2501–2507 (2023). https://doi.org/10.1007/s10072-023-06695-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-06695-y

Keywords

Navigation